Mechanically, we uncovered that treatment with SIS3 inhibited T2DN in db/db mice by inhibiting Smad3 while upregulating Smad7, thereby restoring the balance of Smad3/7 signaling and protecting the kidney from the development of progressive renal fibrosis in db/db mice. Here, SMAD7 is linked to renal fibrosis.